Search
Search
Journalism from the heart of crises
  1. Home
  2. Africa

Drug giant to clamp down on diverting of ARVs

    JOHANNESBURG
    International drug giant GlaxoSmithKline (GSK) says it is close to implementing measures to stem the illegal diversion of anti-AIDS drugs from developing countries to wealthy nations. According to London's Financial Times, by the end of this year the company aims to have implemented an anti-fraud identification system that includes new packaging and labelling for its antiretrovirals (ARVs). Medicines heading for Africa will be coated red and shipped in packaging with easily traceable identity codes, while medication destined for Western markets will remain white in colour. The measure is expected to enable GSK to identify specific wholesalers in Africa, who have been selling humanitarian drugs, as well as the suppliers profiting from such parallel importing into Europe.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Get the day’s top headlines in your inbox every morning

    Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

    DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

    Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

    It’s the perfect way to start your day.

    Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join